Skip to main content
Glama

Fda Drug Competition

by io.github.pipeworx-io
OverviewAdmin

Polymarket Fill Risk

polymarket_fill_risk
Read-onlyIdempotent

Realizable-vs-theoretical edge check against live CLOB order-book depth. REQUIRES one of market (single-market mode) or event (basket/partition mode). SINGLE-MARKET: pass a market slug/URL + side (buy_yes|sell_yes|buy_no|sell_no, default buy_yes) + size_usd (default 1000 — max spend on buys, target proceeds on sells); walks the ladder and returns top_of_book, vwap_fill_price, slippage_pp, shares_filled, max_fillable_usd, and a verdict (clean|degraded|cannot_fill). BASKET: pass an event slug/URL + side (sell_yes = capture overround by selling every leg, buy_yes = capture underround; default auto from partition sum) + size_usd interpreted as settlement notional S (shares per leg; each share pays $1); returns theoretical_sum vs realizable_sum (top-of-book vs VWAP across all legs), capture_ratio, profit_usd at executed size, per-leg fill detail, thin_legs[], max_clean_notional_usd, and forced_directional_risk naming the legs most likely to strand you unhedged. USE THIS before acting on any polymarket_arbitrage SELL/BUY-EVERY-LEG signal or any polymarket_edges trade above ~$500 — theoretical overround on thin books is not capturable, and partial basket fills convert an arb into an unhedged directional position (the dominant loss mode in real arb-bot P&L).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
sideNoSingle-market: buy_yes | sell_yes | buy_no | sell_no (default buy_yes). Basket: sell_yes | buy_yes (default auto — sell if partition sum > 1, buy if < 1).
eventNoBasket mode: event slug or full polymarket.com URL — checks every leg of the partition.
marketNoSingle-market mode: market slug or full polymarket.com URL.
size_usdNoSingle-market: USD to spend (buys) or target proceeds (sells). Basket: settlement notional — shares per leg, each paying $1 at resolution. Default 1000, clamp 10–1,000,000.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.7/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations (readOnlyHint: true, etc.) already indicate a safe read operation. Description adds useful behavioral context: walks the order-book ladder, returns fill details, slippage, and risk warnings like forced_directional_risk. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is long but well-structured with clear section labels (SINGLE-MARKET, BASKET). All sentences add value; no filler. Could be slightly shorter but complexity justifies length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, description thoroughly lists return fields for both modes, including risk indicators and verdicts. It covers prerequisites (requires market or event), explains edge cases (thin books, partial fills), and provides enough detail for an agent to use the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, but description adds significant value: clarifies market vs event mutual exclusivity, explains side defaults per mode, and defines size_usd interpretation (max spend vs target proceeds vs settlement notional). This goes well beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: 'Realizable-vs-theoretical edge check against live CLOB order-book depth'. It distinguishes from siblings by explicitly directing use before acting on polymarket_arbitrage signals or polymarket_edges trades above ~$500, differentiating it from those tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Description provides explicit when-to-use guidance: before acting on polymarket_arbitrage signals or polymarket_edges trades above ~$500. It explains why (unrealizable edge, unhedged directional risk) and implicitly defines when not needed (small trades). Alternatives are named in sibling tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Fda Drug Competition toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources